Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrieu

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Pathologie-Biologie|January 1, 1977
[Levamisole, stimulant of the immune system in animal and man (author's transl)]J M Andrieu
Annales De Medecine Interne|January 1, 1985
[Treatment of primary bronchopulmonary cancers: current prospects]J M Andrieu
Annales De Medecine Interne|January 1, 1982
[Treatment of Hodgkin's disease]J M Andrieu
The Journal of Infectious Diseases|May 1, 1993
Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reactionW Lu, J M Andrieu
Journal of Virology|January 1, 1992
Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sourcesW Lu, J M Andrieu
Acta Haematologica|January 1, 1983
Hyponatremia associated with angioimmunoblastic lymphadenopathyN Colbert, J M Andrieu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIBP Cramer, J M Andrieu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?J M Andrieu, P Colonna
Blood|July 13, 2000
HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanismW Lu, J M Andrieu
Immunology Today|January 1, 1995
Viro-immunopathogenesis of HIV disease: implications for therapyJ M Andrieu, W Lu
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Pathologie-Biologie|January 1, 1977
[Levamisole, stimulant of the immune system in animal and man (author's transl)]J M Andrieu
Annales De Medecine Interne|January 1, 1985
[Treatment of primary bronchopulmonary cancers: current prospects]J M Andrieu
Annales De Medecine Interne|January 1, 1982
[Treatment of Hodgkin's disease]J M Andrieu
The Journal of Infectious Diseases|May 1, 1993
Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reactionW Lu, J M Andrieu
Journal of Virology|January 1, 1992
Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sourcesW Lu, J M Andrieu
Acta Haematologica|January 1, 1983
Hyponatremia associated with angioimmunoblastic lymphadenopathyN Colbert, J M Andrieu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIBP Cramer, J M Andrieu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?J M Andrieu, P Colonna
Blood|July 13, 2000
HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanismW Lu, J M Andrieu
Immunology Today|January 1, 1995
Viro-immunopathogenesis of HIV disease: implications for therapyJ M Andrieu, W Lu
Pageof 16